RBC Capital raised the firm’s price target on Cameco (CCJ) to C$160 from C$110 and keeps an Outperform rating on the shares. Cameco/Brookfield partnering with the U.S. government could help pave the way for a major nuclear new-build program in the US and Western-aligned countries, the analyst tells investors in a research note. Cameco, Westinghouse and the AP1000 reactor design are also uniquely well-positioned to play a critical role in the growing nuclear industry, the firm added.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCJ:
